← Eichor
Study identifier: NCT06994845 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

Condition: Primary Immunoglobulin A Nephropathy (IgAN)  ·  Sponsor: Novartis Pharmaceuticals

PhasePhase 3
Planned participants31
Who can joinAll sexes, 2 Years to 18 Years
Healthy volunteersNo

About this study

The study is an open-label, single arm, multicenter, Phase III study to determine proteinuria reduction, pharmacokinetics (PK), safety and tolerability (including CV surveillance) of iptacopan in primary immunoglobulin A nephropathy (IgAN) pediatric patients aged 2 to \<18 years.

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals  ·  1-888-669-6682  ·  novartis.email@novartis.com

Novartis Pharmaceuticals  ·  +41613241111

Always discuss trial participation with your own doctor first.

Locations (17)

Childrens Hospital ColoradoAurora, Colorado, United StatesRecruiting
Childrens Hospital of PhiladelphiaPhiladelphia, Pennsylvania, United StatesRecruiting
Prim Childrens Hosp Inv PharmSalt Lake City, Utah, United StatesRecruiting
Novartis Investigative SiteBrisbane, Queensland, AustraliaRecruiting
Novartis Investigative SiteNedlands, Western Australia, AustraliaRecruiting
Novartis Investigative SiteHangzhou, Zhejiang, ChinaRecruiting
Novartis Investigative SiteBeijing, ChinaRecruiting
Novartis Investigative SiteHong Kong, Hong KongRecruiting
Novartis Investigative SiteBeersheba, IsraelRecruiting
Novartis Investigative SiteHaifa, IsraelRecruiting
Novartis Investigative SiteJerusalem, IsraelRecruiting
Novartis Investigative SitePetah Tikva, IsraelRecruiting

+ 5 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06994845